acute kidney injury - Nursing Case Study
Pathophysiology
• Primary mechanism: Acute kidney injury (AKI) often begins with reduced blood flow to the kidneys, known as prerenal azotemia. This can result from dehydration, heart failure, or shock, leading to decreased glomerular filtration rate (GFR) and impaired kidney function.
• Secondary mechanism: Tubular injury is another critical mechanism, frequently due to ischemia or nephrotoxic agents like certain medications. Damaged tubular cells can lead to obstruction and back-leak of filtrate, further diminishing renal function.
• Key complication: If untreated, AKI can progress to chronic kidney disease, highlighting the importance of early detection and management to prevent long-term damage and maintain electrolyte and fluid balance.
Patient Profile
Demographics:
58-year-old male, construction worker
History:
• Key past medical history: Hypertension, Type 2 Diabetes Mellitus
• Current medications: Lisinopril, Metformin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Decreased urine output and fatigue
• Key symptoms: Nausea, swelling in legs, shortness of breath
• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 22 breaths per minute, temperature 99.1°F, oxygen saturation 94% on room air
Section 1
As the healthcare team initiates the initial assessment, several key findings emerge that provide insight into the patient's condition. Physical examination reveals pitting edema in both lower extremities, indicating fluid overload, and bilateral crackles upon auscultation of the lungs, suggestive of pulmonary congestion. These findings align with the patient's complaints of shortness of breath and swelling, raising concerns about potential heart failure exacerbating the prerenal azotemia. Initial laboratory results show elevated blood urea nitrogen (BUN) and creatinine levels, confirming impaired renal function. Furthermore, the patient's potassium level is noted to be 5.8 mEq/L, indicating hyperkalemia, a common complication of acute kidney injury that requires prompt attention due to the risk of cardiac arrhythmias.
The clinical picture prompts the team to consider the underlying causes of the acute kidney injury, with a strong suspicion of decreased renal perfusion due to potential volume depletion or cardiac dysfunction. Given the patient's history of hypertension and diabetes, there is a heightened risk for cardiovascular complications, which may be contributing to the current renal issues. The healthcare team decides to initiate careful fluid resuscitation to improve renal perfusion while monitoring for signs of fluid overload, given the existing pulmonary congestion. Additionally, the team plans to adjust the patient's medications, particularly evaluating the use of Lisinopril, which although beneficial for controlling hypertension, may exacerbate hyperkalemia and renal impairment in the current context.
As the patient receives initial interventions, ongoing assessment is crucial to evaluate the response and adjust the treatment plan accordingly. The next steps will include continuous monitoring of urine output and renal function markers, as well as electrocardiographic monitoring due to the elevated potassium level. The healthcare team remains vigilant for further complications, such as worsening electrolyte imbalances or the need for renal replacement therapy, as they work to stabilize the patient's condition and prevent progression to chronic kidney disease.
Section 2
New Complications
As the healthcare team closely monitors the patient's response to the initial interventions, new complications arise that warrant immediate attention. Despite careful fluid resuscitation, the patient's condition begins to deteriorate, evident by increasing respiratory distress and the development of tachypnea, with a respiratory rate climbing to 28 breaths per minute. Arterial blood gas analysis reveals respiratory acidosis, with a pH of 7.31 and elevated pCO2 levels, indicating inadequate ventilation likely due to worsening pulmonary congestion. Concurrently, the patient's oxygen saturation has dropped to 88% on room air, necessitating supplemental oxygen therapy to maintain adequate oxygenation. These findings suggest that the fluid overload and pulmonary congestion are not adequately controlled, possibly due to underlying cardiac dysfunction.
Further complicating the situation, the patient's repeat laboratory tests show a rising potassium level, now at 6.2 mEq/L, exacerbating the risk of life-threatening cardiac arrhythmias. An urgent electrocardiogram (ECG) is performed, revealing peaked T waves, a hallmark of hyperkalemia, necessitating immediate intervention. The healthcare team initiates measures to stabilize the potassium level, including administering calcium gluconate to protect the heart, insulin and glucose to drive potassium back into the cells, and considering the use of diuretics to enhance renal excretion of potassium, while being cautious of the patient's fluid status.
The emergence of these complications prompts the team to re-evaluate the patient's overall management strategy. There is growing concern about the potential need for renal replacement therapy, such as dialysis, if the patient's renal function continues to decline or if severe electrolyte imbalances persist despite medical intervention. The team remains vigilant, continuously assessing the patient's vital signs, renal function, and electrolytes, while also preparing for potential escalation in care to prevent further deterioration. This critical juncture underscores the importance of dynamic clinical reasoning and rapid adaptation of the treatment plan to address the evolving challenges in the patient's acute kidney injury.
Section 3
As the healthcare team continues to manage the patient's acute kidney injury and associated complications, new diagnostic results provide crucial insights into the underlying issues. A transthoracic echocardiogram is performed to assess the potential cardiac dysfunction contributing to the pulmonary congestion and fluid overload. The echocardiogram reveals significant left ventricular systolic dysfunction with an ejection fraction of 35%, indicating heart failure with reduced ejection fraction (HFrEF). This finding aligns with the observed respiratory distress and necessitates a tailored approach to manage both the cardiac and renal aspects of the patient's condition.
In light of the new diagnosis, the treatment plan is adjusted to incorporate medications that address heart failure, including the initiation of an ACE inhibitor to reduce cardiac workload and improve cardiac output. Additionally, the team carefully titrates diuretics to manage fluid overload while closely monitoring renal function and electrolytes. Despite these measures, the patient's renal function continues to decline, evidenced by worsening creatinine levels now at 3.8 mg/dL, underscoring the delicate balance required in managing heart and kidney failure concurrently.
The patient's laboratory results also reveal persistent hyperkalemia, despite initial interventions. Given the refractory nature of the electrolyte imbalance and the critical role of effective potassium management in preventing cardiac complications, the healthcare team decides to initiate renal replacement therapy. A nephrologist is consulted to facilitate the start of dialysis, aiming to stabilize the patient’s electrolyte levels and support renal function. This decision represents a pivotal step in the patient's care, highlighting the complexity of managing multifaceted conditions and the necessity for coordinated, interdisciplinary strategies to optimize outcomes.
Section 4
As the patient begins renal replacement therapy, the healthcare team closely monitors their response to the intervention. Initially, there is a modest improvement in electrolyte levels, with serum potassium decreasing to 5.4 mEq/L. However, the patient's blood pressure becomes more labile, with readings fluctuating between 88/54 mmHg and 112/68 mmHg. This instability raises concerns about potential hemodynamic effects of dialysis on the patient's compromised cardiac output. In response, the team adjusts the dialysis parameters to minimize rapid fluid shifts and avoid exacerbating hypotension, while continuing to address fluid overload.
Despite these adjustments, new complications arise. The patient develops increasing fatigue and confusion, prompting a thorough neurological assessment. The neurologic exam reveals mild disorientation and asterixis, suggestive of uremic encephalopathy. The patient's blood urea nitrogen (BUN) levels remain elevated at 98 mg/dL, reflecting inadequate clearance of nitrogenous waste products. This finding underscores the need for ongoing renal support and prompts discussion about the potential need to adjust the dialysis schedule to more frequent sessions.
Concurrently, the patient's respiratory status remains tenuous, with persistent crackles noted on auscultation and oxygen saturation levels hovering around 90% on 2L of supplemental oxygen. The team recognizes the interplay of cardiac and renal insufficiency in contributing to these symptoms and considers further optimization of heart failure management. The decision to increase the ACE inhibitor dosage is weighed against the risk of worsening renal function. The collaborative approach of the interdisciplinary team, including cardiology, nephrology, and critical care specialists, remains crucial in navigating these complex challenges, as they aim to stabilize the patient and prevent further complications. This dynamic situation calls for vigilant monitoring and ongoing reassessment to adjust the treatment plan effectively.
Section 5
As the healthcare team continues to closely monitor the patient, new diagnostic results reveal a concerning elevation in serum creatinine levels, now at 4.8 mg/dL, indicating a persistent decline in renal function despite ongoing dialysis. This finding, coupled with the elevated BUN, suggests that the current dialysis regimen may not be sufficiently addressing the patient's metabolic needs, necessitating a reevaluation of the dialysis strategy. The team considers increasing the frequency of dialysis sessions to enhance the clearance of nitrogenous waste products and improve overall metabolic balance. Additionally, a repeat echocardiogram is performed to assess cardiac function, revealing a reduced ejection fraction of 35%, which further complicates the management of fluid balance and necessitates a delicate adjustment of diuretics to prevent fluid overload while avoiding exacerbation of hypotension.
Simultaneously, the patient's respiratory status deteriorates, with increased work of breathing and a drop in oxygen saturation to 86% despite supplemental oxygen. A chest X-ray reveals worsening pulmonary congestion, indicative of fluid overload secondary to cardiac and renal dysfunction. In response, the interdisciplinary team, including cardiology and nephrology, collaborates to optimize heart failure management, cautiously titrating diuretics and considering the introduction of a low-dose beta-blocker to support cardiac function without adversely impacting renal perfusion. The team emphasizes the importance of a balanced approach to fluid management, aiming to stabilize the patient's hemodynamic status and improve respiratory function.
These developments underscore the complex interplay between cardiac and renal systems in this patient, highlighting the necessity for vigilant monitoring and dynamic treatment adjustments. The healthcare team remains focused on fine-tuning the therapeutic approach, with an acute awareness of the potential for further complications. The patient's evolving clinical picture calls for ongoing reassessment and responsive intervention to prevent further decline and work towards stabilization and recovery.